diabetes drugs

MA gears up growth mergers buyout strategy
Biotech

UPDATE: Roche muscles in on obesity market with $2.7B Carmot buy

The takeover will give Roche control of Carmot's clinical-phase injectable dual GLP-1/GIP receptor agonists and oral GLP-1 drug candidate.
poker all in chips go yes bet

Vertex doubles down on CRISPR Tx and diabetes in new $100M deal

Mar 27, 2023 11:41am
scales court

Pfizer accuses former employees of stealing trade secrets

Feb 3, 2022 9:50am
diabetes strip blood glucose monitor

Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues

Jun 28, 2021 5:19pm
Lilly Diabetes

Lilly's next-gen GLP-1 cuts blood sugar in early-stage diabetes

Jun 26, 2021 4:15pm
Lilly

Lilly's tirzepatide hits goal in phase 3 diabetes trial

Dec 9, 2020 8:28am